Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema.
Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema. Ophthalmology. 2013 Sep; 120(9):1835-42.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Bevacizumab
Combined Modality Therapy
Cost-Benefit Analysis
Diabetic Retinopathy
Diagnostic Techniques, Ophthalmological
Drug Costs
Financing, Personal
Glucocorticoids
Health Care Costs
Humans
Intravitreal Injections
Laser Coagulation
Macular Edema
Markov Chains
Middle Aged
Quality-Adjusted Life Years
Ranibizumab
Triamcinolone Acetonide
Vascular Endothelial Growth Factor A
authors with profiles
David Kim